Dr James McLaren
- Honorary Clinical Senior Lecturer (School of Cardiovascular & Metabolic Health)
The University of Glasgow uses cookies for analytics. Find out more about our Privacy policy.
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and can only be disabled by changing your browser preferences.
Analytical cookies help us improve our website. We use Google Analytics. All data is anonymised.
Clarity helps us to understand our users’ behaviour by visually representing their clicks, taps and scrolling. All data is anonymised.
Iliodromiti, S. et al. (2023) Liver, visceral and subcutaneous fat in men and women of South Asian and white European descent: a systematic review and meta-analysis of new and published data. Diabetologia, 66(1), pp. 44-56. (doi: 10.1007/s00125-022-05803-5) (PMID:36224274) (PMCID:PMC9729139)
Celis-Morales, C. A. et al. (2017) Associations between diabetes and both cardiovascular disease and all-cause mortality are modified by grip strength: evidence from UK Biobank, a prospective population-based cohort study. Diabetes Care, 40(12), pp. 1710-1718. (doi: 10.2337/dc17-0921) (PMID:28986505)
Sattar, N. , McLaren, J., Kristensen, S. L., Preiss, D. and McMurray, J. J.V. (2016) SGLT2 and cardiovascular events: why did EMPA-REG Outcomes surprise and what were the likely mechanisms? Diabetologia, 59(7), pp. 1333-1339. (doi: 10.1007/s00125-016-3956-x) (PMID:27112340) (PMCID:PMC4901113)
Sattar, N. , McLaren, J., Kristensen, S. L., Preiss, D. and McMurray, J. J. (2016) Erratum to: SGLT2 Inhibition and cardiovascular events: why did EMPA-REG Outcomes surprise and what were the likely mechanisms? Diabetologia, 59(7), pp. 1573-1574. (doi: 10.1007/s00125-016-3987-3) (PMID:27174369) (PMCID:PMC4969788)
McLaren, J., McKay, G. and Fisher, M. (2013) Lorcaserin. Practical Diabetes, 30(3), pp. 136-137. (doi: 10.1002/pdi.1760)
Iliodromiti, S. et al. (2023) Liver, visceral and subcutaneous fat in men and women of South Asian and white European descent: a systematic review and meta-analysis of new and published data. Diabetologia, 66(1), pp. 44-56. (doi: 10.1007/s00125-022-05803-5) (PMID:36224274) (PMCID:PMC9729139)
Celis-Morales, C. A. et al. (2017) Associations between diabetes and both cardiovascular disease and all-cause mortality are modified by grip strength: evidence from UK Biobank, a prospective population-based cohort study. Diabetes Care, 40(12), pp. 1710-1718. (doi: 10.2337/dc17-0921) (PMID:28986505)
Sattar, N. , McLaren, J., Kristensen, S. L., Preiss, D. and McMurray, J. J.V. (2016) SGLT2 and cardiovascular events: why did EMPA-REG Outcomes surprise and what were the likely mechanisms? Diabetologia, 59(7), pp. 1333-1339. (doi: 10.1007/s00125-016-3956-x) (PMID:27112340) (PMCID:PMC4901113)
Sattar, N. , McLaren, J., Kristensen, S. L., Preiss, D. and McMurray, J. J. (2016) Erratum to: SGLT2 Inhibition and cardiovascular events: why did EMPA-REG Outcomes surprise and what were the likely mechanisms? Diabetologia, 59(7), pp. 1573-1574. (doi: 10.1007/s00125-016-3987-3) (PMID:27174369) (PMCID:PMC4969788)
McLaren, J., McKay, G. and Fisher, M. (2013) Lorcaserin. Practical Diabetes, 30(3), pp. 136-137. (doi: 10.1002/pdi.1760)